Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Friedreich's Ataxia
Biotech
PTC bounces back with positive data on FA prospect vatiquinone
Several months after forging a path forward for its Friedreich ataxia drug vatiquinone, PTC Therapeutics is back with some much-needed good news.
Fraiser Kansteiner
Oct 8, 2024 9:34am
Lexeo links gene therapy to improvements in rare heart disease
Jul 15, 2024 9:46am
FDA picks Denali, Neurogene and more for rare disease program
Jun 4, 2024 2:51pm
Larimar's Friedreich's ataxia program free at last from FDA hold
May 21, 2024 9:55am
After pair of failures, PTC finds path for Friedreich ataxia med
Mar 1, 2024 9:20am
FDA demands data on 2 PTC candidates, delaying filing
Oct 27, 2023 7:30am
